Ryan Brinkman

Stock Analyst at JP Morgan

(2.31)
# 2,502
Out of 4,839 analysts
260
Total ratings
48.88%
Success rate
-7.83%
Average return

Stocks Rated by Ryan Brinkman

Avis Budget Group
May 9, 2025
Maintains: Overweight
Price Target: $145$155
Current: $108.97
Upside: +42.24%
Lear Corporation
May 9, 2025
Maintains: Overweight
Price Target: $119$120
Current: $91.14
Upside: +31.67%
Visteon
May 5, 2025
Maintains: Neutral
Price Target: $90$97
Current: $83.87
Upside: +15.66%
Ford Motor Company
May 1, 2025
Maintains: Overweight
Price Target: $11$12
Current: $10.48
Upside: +14.50%
Camping World Holdings
May 1, 2025
Upgrades: Overweight
Price Target: $23$21
Current: $15.76
Upside: +33.25%
Rivian Automotive
Apr 25, 2025
Maintains: Underweight
Price Target: $11$10
Current: $16.34
Upside: -38.80%
Tesla
Apr 23, 2025
Maintains: Underweight
Price Target: $120$115
Current: $334.62
Upside: -65.63%
Ferrari
Mar 27, 2025
Maintains: Overweight
Price Target: $525$460
Current: $496.12
Upside: -7.28%
General Motors Company
Mar 27, 2025
Maintains: Overweight
Price Target: $64$53
Current: $49.37
Upside: +7.35%
OPENLANE
Mar 27, 2025
Downgrades: Neutral
Price Target: $23$20
Current: $22.12
Upside: -9.58%
Maintains: Neutral
Price Target: $34$32
Current: $22.15
Upside: +44.47%
Maintains: Neutral
Price Target: $56$51
Current: $27.00
Upside: +88.89%
Maintains: Overweight
Price Target: $14$20
Current: $15.74
Upside: +27.06%
Maintains: Overweight
Price Target: $51$49
Current: $32.71
Upside: +49.80%
Maintains: Neutral
Price Target: $24$21
Current: $14.90
Upside: +40.94%
Maintains: Overweight
Price Target: $107$113
Current: $66.96
Upside: +68.76%
Downgrades: Underweight
Price Target: n/a
Current: $6.25
Upside: -
Maintains: Overweight
Price Target: $63$55
Current: $35.61
Upside: +54.45%
Maintains: Neutral
Price Target: $117$129
Current: $100.54
Upside: +28.31%
Maintains: Overweight
Price Target: $16$18
Current: $10.50
Upside: +71.43%
Reinstates: Overweight
Price Target: $20
Current: $17.92
Upside: +11.61%
Upgrades: Neutral
Price Target: $16
Current: $61.09
Upside: -73.40%